- Recent Funding
- Investors
- Lewis & Clark Partners
Lewis & Clark Partners portfolio
Lewis & Clark Partners has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Plastomics's $5.8M Series B+ round in October 2025, alongside Missouri Technology Corporation, Fulcrum Global Capital, BioGenerator Ventures and 1 other. That company is in Health and bio.
What Lewis & Clark Partners invests in
- Health and bio · 1 · 100%
- Commerce and retail · 1 · 100%
How Lewis & Clark Partners invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $5.8M |
Lewis & Clark Partners portfolio companies
PPlastomics$5.8MSeries B+ · Oct 2025
| Company | Round with Lewis & Clark Partners | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $5.8M | $12.9M | Oct 27, 2025 Series B+ |
Most frequent co-investors
MMissouri Technology Corporation1 shared round · last Oct 27, 2025
FFulcrum Global Capital1 shared round · last Oct 27, 2025
BBioGenerator Ventures1 shared round · last Oct 27, 2025
SSkull Diamond And Heart Capital1 shared round · last Oct 27, 2025
Similar investors
AAxiom Asia Private Capital1 company · 1 deal in 12 mo
BBeach Point Capital Management1 company · 1 deal in 12 mo
OOui Capital1 company · 1 deal in 12 mo
RRS Participaties1 company · 1 deal in 12 mo
SSelva Ventures1 company · 1 deal in 12 mo
TTheVentures1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Lewis & Clark Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Lewis & Clark Partners, which is a subset of its real portfolio. API: /api/v1/investors/lewis-clark-partners (get a free API key). More: the most active VC firms and new venture capital funds.